In addition to monogenic forms, PD risk is influenced by multiple genetic variants across the genome, each contributing small effects. Genome-wide association studies (GWAS) have identified numerous common genetic variants associated with an increased risk of PD. These variants are located in or near genes involved in various pathways, including α-synuclein aggregation, lysosomal function, immune response, and synaptic transmission.